Az amurgéb (Perccottus glenii Dybowski, 1877) egy álló- és egy folyóvízi populációjának táplálkozásökológiai vizsgálata

Az utóbbi két évtizedben a Távol‐Keletről származó amurgéb (Perccottus glenii) inváziója figyelhető meg Kelet‐ és Közép‐Európában. Munkánk során az amurgéb évszakonkénti részletes táplálkozásökológiai elemzését tűztük ki célul egy állóvízben (a Rakamaz-Tiszanagyfalui‐Nagy‐morotvában) és egy vízfolyásban (a Lónyay‐főcsatornában). A legjelentősebb táplálékszervezeteknek az árvaszúnyogok (Chironomidae), szitakötők (Odonata), rákok (Crustacea) és kérészek (Ephemeroptera) bizonyultak. A faj táplálkozásának intenzitásában nem tapasztalható méret, évszak és hely által befolyásolt változás. Táplálékának összetételét legfőképp a halak mérete befolyásolja, amelynek hatása erősebbnek bizonyult az élőhelyi és évszakos hatásoknál is. Kutatásaink igazolják, hogy az amurgé a vízi táplálékhálózat számos szintjét (kompartmentjét) befolyásolhatja, elsősorban azonban a makroszkopikus gerinctelen szervezetek hatékony predátora

Muscle flaps – an alternative for decortication or resection to solve the residual space in impaired patients

Universitatea de Medicină și Farmacie „Victor Babeș”, Clinica I Chirurgie, Spitalul Clinic Judeţean de Urgenţă „Pius Brinzeu”, Clinica de Chirurgie Toracică, Spitalul Clinic Municipal de Urgenţă, Timișoara, România, Al XIII-lea Congres al Asociației Chirurgilor „Nicolae Anestiadi” și al III-lea Congres al Societății de Endoscopie, Chirurgie miniminvazivă și Ultrasonografie ”V.M.Guțu” din Republica MoldovaIntroducere: Decorticările sau rezecțiile pulmonare reprezintă tratamentul chirurgical obişnuit în cazul pacienților cu empiem sau abcese pulmonare cronice. Pentru un număr redus de pacienți cu comorbidități severe asociate sau disfuncții respiratorii aceste operații nu sunt indicate. Am analizat eficiența lambourilor musculare pentru a corecta cavitățile reziduale. Material și metode: Am studiat pacienți cu scor de risc ASA >3, cu FEV si FVC<40, clasa NYHA mai mare sau egală cu II. Am inclus în studiu pacienți cu empiem (1caz), aspergiliom (8 cazuri), abces pulmonar cronic (1 caz) .Am folosit diverse lambouri musculare pentru a umple cavitățile. Pentru pacienții cu aspergilom am practicat toracotomie, cavernotomie, excizia micetomului, sutura fistulei. Am folosit lambouri din pectoralul mare (2), muşchii intercostali (4) şi dorsal mare (2). Pentru pacienții cu supurații cronice pulmonare am folosit dorsal mare, iar pentru empiem am asociat şi muşchi pectoral mare, trapez şi intercostal cu toracoplastie. Rezultate: Evoluția imediată a fost favorabilă în toate cazurile cu excepția unuia care a necesitat reintervenție pentru sângerare. Un pacient a dezvoltat serom. În toate cazurile, viabilitatea lamboului nu a fost afectată. Nu s-au inregistrat decese. Concluzii: Scopul acestor intervenții a fost sa eliminăm spațiile libere din pleură sau plămân. Pentru pacienții tarați, decorticările şi rezecțiile sunt operații riscante, această nouă abordare fiind benefică. Evoluția favorabilă, morbiditatea minimă după folosirea lambourilor musculare justifică deplin acest procedeu. Chiar dacă numărul mic de cazuri în care am practicat acest tip de operație ne limitează pentru moment spectrul de experiență, rezultatele pozitive sunt încurajatoare.Introduction: The surgical treatment of residual space for patients with empyema or chronic lung abscess is in most cases decortication or lung resection. For a limited number of patients with severe comorbidities or respiratory dysfunction these procedures are prohibited. We analyzed the efficiency of muscle flaps to solve the residual cavities these patients. Material and methods: We studied patients with ASA risk > 3, with FEV and FVC < 40%, NYHA II or more. Patients with empyema (1 case), aspergilloma (8 cases), chronic lung abscess (1 case) were included in the study. Different types of muscle flaps were used to fill the cavities. For patients with aspergilloma we performed thoracotomy, cavernotomy, excision of the micetoma, fistulae suture; muscles used: pectoris major – 2, intercostal – 4 and latissimus dorsi – 2. For the patient with chronic suppuration of the lung we used latissimus, and for the empyema we associated pectoris major, trapezius and intercostal muscle with thoracoplasty. Results: The immediate outcome was favorable in all cases except one who required exploration for bleeding. One patient developed wound seroma. In all cases the viability of the transposed muscle was not affected. We recorded no mortality. Conclusions: The aim of surgery is to eliminate all empty space in the pleura or lung. For impaired patients decortication or resection are very risky, thus new approach was needed. The good outcome, minimal morbidity after using muscle flaps, fully justify their use. The low number of patients limits our experience, but the good results are encouraging

The ASY-EOS experiment at GSI: investigating the symmetry energy at supra-saturation densities

The elliptic-flow ratio of neutrons with respect to protons in reactions of neutron rich heavy-ions systems at intermediate energies has been proposed as an observable sensitive to the strength of the symmetry term in the nuclear Equation Of State (EOS) at supra-saturation densities. The recent results obtained from the existing FOPI/LAND data for $^{197}$Au+$^{197}$Au collisions at 400 MeV/nucleon in comparison with the UrQMD model allowed a first estimate of the symmetry term of the EOS but suffer from a considerable statistical uncertainty. In order to obtain an improved data set for Au+Au collisions and to extend the study to other systems, a new experiment was carried out at the GSI laboratory by the ASY-EOS collaboration in May 2011.Comment: Talk given by P. Russotto at the 11th International Conference on Nucleus-Nucleus Collisions (NN2012), San Antonio, Texas, USA, May 27-June 1, 2012. To appear in the NN2012 Proceedings in Journal of Physics: Conference Series (JPCS

Study of dielectron production in C+C collisions at 1 AGeV

The emission of e+e- pairs from C+C collisions at an incident energy of 1 GeV per nucleon has been investigated. The measured production probabilities, spanning from the pi0-Dalitz to the rho/omega! invariant-mass region, display a strong excess above the cocktail of standard hadronic sources. The bombarding-energy dependence of this excess is found to scale like pion production, rather than like eta production. The data are in good agreement with results obtained in the former DLS experiment.Comment: submitted to Physics Letters

Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose

<p>Abstract</p> <p>Background</p> <p>To provide an initial evaluation of insulin sensitivity and secretion indices derived from a standard liquid meal tolerance test protocol in subjects with normal (NFG), impaired fasting glucose (IFG) or type 2 diabetes mellitus.</p> <p>Methods</p> <p>Areas under the curve (AUC) for glucose, insulin and C-peptide from pre-meal to 120 min after consumption of a liquid meal were calculated, as were homeostasis model assessments of insulin resistance (HOMA2-IR) and the Matsuda index of insulin sensitivity.</p> <p>Results</p> <p>Subjects with NFG (n = 19), IFG (n = 19), and diabetes (n = 35) had mean ± SEM HOMA2-IR values of 1.0 ± 0.1, 1.6 ± 0.2 and 2.5 ± 0.3 and Matsuda insulin sensitivity index values of 15.6 ± 2.0, 8.8 ± 1.2 and 6.0 ± 0.6, respectively. The log-transformed values for these variables were highly correlated overall and within each fasting glucose category (r = -0.91 to -0.94, all p < 0.001). Values for the product of the insulin/glucose AUC ratio and the Matsuda index, an indicator of the ability of the pancreas to match insulin secretion to the degree of insulin resistance, were 995.6 ± 80.7 (NFG), 684.0 ± 57.3 (IFG) and 188.3 ± 16.1 (diabetes) and discriminated significantly between fasting glucose categories (p < 0.001 for each comparison).</p> <p>Conclusion</p> <p>These results provide initial evidence to support the usefulness of a standard liquid meal tolerance test for evaluation of insulin secretion and sensitivity in clinical and population studies.</p

Connection between Telomerase Activity in PBMC and Markers of Inflammation and Endothelial Dysfunction in Patients with Metabolic Syndrome

Metabolic syndrome (MS) is a constellation of metabolic derangements associated with vascular endothelial dysfunction and oxidative stress and is widely regarded as an inflammatory condition, accompanied by an increased risk for cardiovascular disease. The present study tried to investigate the implications of telomerase activity with inflammation and impaired endothelial function in patients with metabolic syndrome. Telomerase activity in circulating peripheral blood mononuclear cells (PBMC), TNF-α, IL-6 and ADMA were monitored in 39 patients with MS and 20 age and sex-matched healthy volunteers. Telomerase activity in PBMC, TNF-α, IL-6 and ADMA were all significantly elevated in patients with MS compared to healthy volunteers. PBMC telomerase was negatively correlated with HDL and positively correlated with ADMA, while no association between TNF-α and IL-6 was observed. IL-6 was increasing with increasing systolic pressure both in the patients with MS and in the healthy volunteers, while smoking and diabetes were positively correlated with IL-6 only in the patients' group. In conclusion, in patients with MS characterised by a strong dyslipidemic profile and low diabetes prevalence, significant telomerase activity was detected in circulating PBMC, along with elevated markers of inflammation and endothelial dysfunction. These findings suggest a prolonged activity of inflammatory cells in the studied state of this metabolic disorder that could represent a contributory pathway in the pathogenesis of atherosclerosis

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURO bservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

Aims: Given the advances in atrial fibrillation (AF) management and the availability of new European Society of Cardiology (ESC) guidelines, there is a need for the systematic collection of contemporary data regarding the management and treatment of AF in ESC member countries. Methods and results: We conducted a registry of consecutive in- and outpatients with AF presenting to cardiologists in nine participating ESC countries. All patients with an ECG-documented diagnosis of AF confirmed in the year prior to enrolment were eligible. We enroled a total of 3119 patients from February 2012 to March 2013, with full data on clinical subtype available for 3049 patients (40.4% female; mean age 68.8 years). Common comorbidities were hypertension, coronary disease, and heart failure. Lone AF was present in only 3.9% (122 patients). Asymptomatic AF was common, particularly among those with permanent AF. Amiodarone was the most common antiarrhythmic agent used (~20%), while beta-blockers and digoxin were the most used rate control drugs. Oral anticoagulants (OACs) were used in 80% overall, most often vitamin K antagonists (71.6%), with novel OACs being used in 8.4%. Other antithrombotics (mostly antiplatelet therapy, especially aspirin) were still used in one-third of the patients, and no antithrombotic treatment in only 4.8%. Oral anticoagulants were used in 56.4% of CHA 2DS2-VASc = 0, with 26.3% having no antithrombotic therapy. A high HAS-BLED score was not used to exclude OAC use, but there was a trend towards more aspirin use in the presence of a high HAS-BLED score. Conclusion: The EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry has provided systematic collection of contemporary data regarding the management and treatment of AF by cardiologists in ESC member countries. Oral anticoagulant use has increased, but novel OAC use was still low. Compliance with the treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal. © The Author 2013

Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry

Background: Atrial fibrillation (AF) and renal impairment share a bidirectional relationship with important pathophysiological interactions. We evaluated the impact of renal impairment in a contemporary cohort of patients with AF. Methods: We utilised the ESC-EHRA EORP-AF Long-Term General Registry. Outcomes were analysed according to renal function by CKD-EPI equation. The primary endpoint was a composite of thromboembolism, major bleeding, acute coronary syndrome and all-cause death. Secondary endpoints were each of these separately including ischaemic stroke, haemorrhagic event, intracranial haemorrhage, cardiovascular death and hospital admission. Results: A total of 9306 patients were included. The distribution of patients with no, mild, moderate and severe renal impairment at baseline were 16.9%, 49.3%, 30% and 3.8%, respectively. AF patients with impaired renal function were older, more likely to be females, had worse cardiac imaging parameters and multiple comorbidities. Among patients with an indication for anticoagulation, prescription of these agents was reduced in those with severe renal impairment, p&nbsp;&lt;.001. Over 24&nbsp;months, impaired renal function was associated with significantly greater incidence of the primary composite outcome and all secondary outcomes. Multivariable Cox regression analysis demonstrated an inverse relationship between eGFR and the primary outcome (HR 1.07 [95% CI, 1.01–1.14] per 10&nbsp;ml/min/1.73&nbsp;m2 decrease), that was most notable in patients with eGFR &lt;30&nbsp;ml/min/1.73&nbsp;m2 (HR 2.21 [95% CI, 1.23–3.99] compared to eGFR ≥90&nbsp;ml/min/1.73&nbsp;m2). Conclusion: A significant proportion of patients with AF suffer from concomitant renal impairment which impacts their overall management. Furthermore, renal impairment is an independent predictor of major adverse events including thromboembolism, major bleeding, acute coronary syndrome and all-cause death in patients with AF